Patologia: Carcinoma del pancreas esocrino
Osservazionale-Sperimentale: Osservazionale
Monocentrico-Multicentrico: Multicentrico
Randomizzato: No
Fase di studio: Non applicabile
Linee di trattamento: Non applicabile
Criteri di inclusione:
- Males or females over 18 years of age capable of providing informed consent.
- Pancreatic carcinoma confirmed by tissue biopsy or colon mass, clinically consistent with cancer and eventually confirmed by pathology.
- Subject were enrolled following colon cancer screening via colonoscopy
Criteri di esclusione:
- Patients under the age of 18 years or over the age of 80 years.
- Patients with personal history of cancer, identification of large polyp or adenomatous pathology on previous or subsequent colonoscopy
- Patient with history of abdominal surgery within the past four months
- Patients unwilling to or unable to give informed consent.
- Patients with acute inflammatory diseases or under any emergency condition.
- Pregnant women.
Schema di trattamento:
/
Trattamento sperimentale:
Diagnostic Test: Liquid biopsy
Detection and quantification of EMT-transcription factor mRNA levels in blood
Trattamento di controllo:
/
Obiettivi primari dello studio:
The present study is aimed at detecting and measuring mRNA levels of genes involved in epithelial to mesenchymal transition (EMT) in biological samples, i.e. in peripheral blood samples of pancreatic cancer (PC) patients and healthy controls, to determine the presence of disease, its progression and risk of recurrence.
Ospedale San Raffaele di Milano
Via Olgettina 60 - 20132 Milano - MI
Istituto Clinico Humanitas Rozzano
Via Manzoni 56 - 20089 Rozzano - MI
Riferimento: Prof. Luigi Laghi
Telefono: 0282244572
Email: luigi.laghi@humanitas.it
Numero di iscrizione a registro: NCT04323917
Data di inserimento: 03.08.2020
Isituto Clinico Humanitas, Rozzano (Mi)
/
Isituto Clinico Humanitas, Rozzano (Mi)
Riferimento: Prof. Luigi Laghi
Telefono: 0282244572
Email: luigi.laghi@humanitas.it
Localita: Rozzano (Mi)